Methadone Martindale Pharma

Methadone Hydrochloride, the active ingredient in Methadone Martindale, is an opioid analgesic presented as an oral formulation for oral use. It is employed in the management of opioid dependence and for the treatment of chronic pain in adult patients.

GNH USA supplies Methadone Martindale as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methadone is used in opioid‑related disorders and long‑term pain management.

- Opioid dependence: stabilises patients, reduces withdrawal symptoms and supports abstinence. - Chronic pain: provides sustained analgesia for severe, persistent pain unresponsive to other opioids. - Opioid detoxification: facilitates a controlled tapering process during supervised withdrawal programs.

Methadone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Constipation: reduced bowel motility leading to infrequent stools. - Nausea: feeling of queasiness, often transient. - Drowsiness: increased sleepiness or fatigue. - Dry mouth: reduced salivary flow. - Sweating: excessive perspiration. - Dizziness: light‑headed sensation, especially on standing.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - Cardiac arrhythmia: abnormal heart rhythm, including QT prolongation. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, itching, or anaphylaxis. - Seizures: convulsive episodes. - Hepatotoxicity: liver enzyme elevations or liver injury.

Methadone requires careful monitoring due to its potency and risk profile.

- Assess patient history: evaluate prior opioid use, respiratory conditions and cardiac disease. - Initiate low dose: start with the smallest effective dose and titrate slowly. - Monitor QT interval: obtain baseline ECG and repeat if clinically indicated. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal. - Counsel on driving: advise patients not to operate machinery until they know how the drug affects them. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Methadone interacts with several drug classes that can alter its safety or efficacy.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase methadone plasma levels and risk of toxicity. - QT‑prolonging agents (e.g., haloperidol, quinidine): additive risk of cardiac arrhythmias. - CNS depressants (e.g., benzodiazepines, alcohol): potentiate respiratory depression.

Moderate Interactions (Monitor Closely): - CYP2B6 inducers (e.g., rifampicin, carbamazepine): may reduce methadone concentrations, leading to withdrawal. - Antidepressants (e.g., SSRIs): can affect methadone metabolism and QT interval. - Herbal supplements (e.g., St John’s wort): may alter hepatic enzyme activity and affect drug levels.